Santhera Pharmaceuticals Holding AG: Santhera's Shareholders Approve all Board Proposals at Today's Annual General Meeting
Pratteln, Switzerland, June 30, 2022 - Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Annual General Meeting (AGM) held